BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35754032)

  • 1. Prognostic implication of bronchoalveolar lavage fluid analysis in patients with Pneumocystis jirovecii pneumonia without human immunodeficiency virus infection.
    Chung C; Lim CM; Oh YM; Hong SB; Choi CM; Huh JW; Lee SW; Lee JS; Jo KW; Ji W; Park CJ; Kim M; Sung H; Cho YU; Cho HS; Kim HC
    BMC Pulm Med; 2022 Jun; 22(1):251. PubMed ID: 35754032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular profiles of bronchoalveolar lavage fluid and their prognostic significance for non-HIV-infected patients with Pneumocystis jirovecii pneumonia.
    Lee JY; Park HJ; Kim YK; Yu S; Chong YP; Kim SH; Sung H; Lee SO; Kim MN; Lim CM; Kim YS; Koh Y; Woo JH; Choi SH
    J Clin Microbiol; 2015 Apr; 53(4):1310-6. PubMed ID: 25673796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?].
    Gazaignes S; Bergeron A; Menotti J; Desseaux K; Molina JM; De Castro N
    Rev Mal Respir; 2020 Apr; 37(4):299-307. PubMed ID: 32273116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Performance of BAL Metagenomic Next-Generation Sequence and Serum (1,3)-β-D-Glucan for Differential Diagnosis of
    Liu L; Yuan M; Shi Y; Su X
    Front Cell Infect Microbiol; 2021; 11():784236. PubMed ID: 35004353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veno-Venous Extracorporeal Membrane Oxygenation for Severe Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient without HIV Infection.
    Nureki SI; Usagawa Y; Watanabe E; Takenaka R; Shigemitsu O; Abe T; Yasuda N; Goto K; Kitano T; Kadota JI
    Tohoku J Exp Med; 2020 Apr; 250(4):215-221. PubMed ID: 32249237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study.
    Gaborit BJ; Tessoulin B; Lavergne RA; Morio F; Sagan C; Canet E; Lecomte R; Leturnier P; Deschanvres C; Khatchatourian L; Asseray N; Garret C; Vourch M; Marest D; Raffi F; Boutoille D; Reignier J
    Ann Intensive Care; 2019 Nov; 9(1):131. PubMed ID: 31776705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal Pneumocystis jirovecii pneumonia in a HIV-negative adult.
    Haddad TM; Vallabhajosyula S; Nawaz MS; Vivekanandan R
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26311008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis jirovecii colonization in bronchoalveolar lavage among naïve non-small cell lung cancer from tertiary respiratory hospital in Jakarta, Indonesia.
    Zaini J; A'la Al Maududi A; Fillahihasanah T; Rizqy Fadhillah M; Pradono P; Haryanto B; Adawiyah R; Setianingrum F; Rozaliyani A; Syahruddin E
    J Infect Dev Ctries; 2022 Oct; 16(10):1643-1647. PubMed ID: 36332219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the performance of DiaSorin molecular Pneumocystis jirovecii-CMV multiplex real-time PCR assay from bronchoalveolar lavage samples.
    Kilic A; Elliott S; Hester L; Palavecino E
    J Mycol Med; 2020 Jun; 30(2):100936. PubMed ID: 32044156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis jirovecii pneumonia in children. A retrospective study in a single center over three decades.
    García-Moreno J; Melendo-Pérez S; Martín-Gómez MT; Frick MA; Balcells-Ramírez J; Pujol-Jover M; Martín-Nalda A; Mendoza-Palomar N; Soler-Palacín P
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Mar; 38(3):111-118. PubMed ID: 31272810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Diagnosis of
    Goterris L; Mancebo Fernández MA; Aguilar-Company J; Falcó V; Ruiz-Camps I; Martín-Gómez MT
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31578265
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients.
    Huggett JF; Taylor MS; Kocjan G; Evans HE; Morris-Jones S; Gant V; Novak T; Costello AM; Zumla A; Miller RF
    Thorax; 2008 Feb; 63(2):154-9. PubMed ID: 17693588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study.
    Yu Q; Jia P; Su L; Zhao H; Que C
    BMC Infect Dis; 2017 Jun; 17(1):392. PubMed ID: 28583135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV+ patients.
    Blount RJ; Daly KR; Fong S; Chang E; Grieco K; Greene M; Stone S; Balmes J; Miller RF; Walzer PD; Huang L
    PLoS One; 2017; 12(7):e0180212. PubMed ID: 28692651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.
    Su YS; Lu JJ; Perng CL; Chang FY
    J Microbiol Immunol Infect; 2008 Dec; 41(6):478-82. PubMed ID: 19255691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of bronchoalveolar lavage in patients with non-HIV pneumocystis pneumonia.
    Tamai K; Tachikawa R; Tomii K; Nagata K; Otsuka K; Nakagawa A; Otsuka K; Matsumoto T; Monden K; Takeshita J; Tanaka K; Kawamura T; Otoshi T; Fujimoto D
    Intern Med; 2014; 53(11):1113-7. PubMed ID: 24881733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegaloviral or
    Sun YS; Huang DF; Lin FC; Hsu CK; Sun IT; Chang SC; Tsai CY; Lai CC
    J Rheumatol; 2019 Mar; 46(3):251-258. PubMed ID: 30504509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing.
    Huang L; Xu S; Huang Z; Chen Y; Xu N; Xie B
    BMC Pulm Med; 2023 Feb; 23(1):72. PubMed ID: 36829171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?
    Svensson T; Lundström KL; Höglund M; Cherif H
    Ups J Med Sci; 2017 Mar; 122(1):56-60. PubMed ID: 27739337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of metagenomic next-generation sequencing for identifying
    Zhao M; Yue R; Wu X; Gao Z; He M; Pan L
    Front Cell Infect Microbiol; 2022; 12():1026739. PubMed ID: 36389151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.